Indian Journal of Palliative Care
Open access journal 
  Print this page Email this page   Small font sizeDefault font sizeIncrease font size Users online: 331  
     Home | About | Feedback | Login 
  Current Issue Back Issues Editorial Board Authors and Reviewers How to Subscribe Advertise with us Contact Us Analgesic Prescription  
  Navigate Here 
 Search
 
  
 Resource Links
  »  Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
  »  Article in PDF (366 KB)
  »  Citation Manager
  »  Access Statistics
  »  Reader Comments
  »  Email Alert *
  »  Add to My List *
* Registration required (free)  

 
  In this Article
 »  Abstract
 » Introduction
 » Methods
 » Results
 » Discussion
 » Conclusion
 »  References
 »  Article Figures
 »  Article Tables

 Article Access Statistics
    Viewed958    
    Printed25    
    Emailed0    
    PDF Downloaded25    
    Comments [Add]    

Recommend this journal

 


 
Table of Contents 
REVIEW ARTICLE
Year : 2020  |  Volume : 26  |  Issue : 1  |  Page : 110-115

Oral microbiological evidence among palliative patients: An integrated systematic review


1 Pengiran Anak Puteri Rashidah Sa'adatul Bolkiah Institute of Health Sciences, Universiti Brunei Darussalam, Bandar Seri Begawan, Brunei Darussalam
2 Oxford Brookes University, Oxford, United Kingdom

Date of Submission26-Sep-2019
Date of Acceptance02-Nov-2019
Date of Web Publication28-Jan-2020

Correspondence Address:
Dr. Jagjit Singh Dhaliwal
Pengiran Anak Puteri Rashidah Sa'adatul Bolkiah Institute of Health Sciences, Universiti Brunei Darussalam, Bandar Seri Begawan
Brunei Darussalam
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/IJPC.IJPC_178_19

Rights and Permissions

 » Abstract 


Life-limiting diseases such as cancers and its related treatments often compromise normal oral microbial flora and predispose a palliative patient to diverse oral infections. Knowledge on microbial flora in the oral cavity of patients with life-limiting diseases is essential to develop treatment options for clinical practitioners. This review aimed to systematically synthesize the published evidence on the oral microbiology of palliative patients. An integrative review was undertaken with defined search strategy from five databases with manual search through key journals and reference list. Studies included were published during the year 2000–2017 focusing on microbiological evidence associated with oral conditions among palliative patients. Candida presence was reported in the oral cavity of terminally ill patients in seven of nine articles, with Candida albicans being the predominant species. The majority of the included studies used oral swabs as a technique for isolation of the organism. This review is first to systematically synthesize the published evidence on the oral microbial flora of palliative patients, taking into account the techniques for identification of the microbiota. Larger multicenter studies may help in developing standardized clinical guidelines for the oral care of these patients.


Keywords: Cancer, Candida, microbial flora, oral care, terminally ill


How to cite this article:
Dhaliwal JS, Murang ZR, Ramasamy DT, Venkatasalu MR. Oral microbiological evidence among palliative patients: An integrated systematic review. Indian J Palliat Care 2020;26:110-5

How to cite this URL:
Dhaliwal JS, Murang ZR, Ramasamy DT, Venkatasalu MR. Oral microbiological evidence among palliative patients: An integrated systematic review. Indian J Palliat Care [serial online] 2020 [cited 2020 Jul 14];26:110-5. Available from: http://www.jpalliativecare.com/text.asp?2020/26/1/110/276870





 » Introduction Top


The oral cavity of humans is coated with a plethora of microorganisms.[1] Although most of these are considered as “beneficial flora” and have a useful purpose in the body, any imbalance can create a widespread havoc to general and oral health of the individual.[2]Candida species are normally present as commensals in the oral cavity with 30%–50% of a healthy individual carrying Candida albicans (C. albicans).[2] However, conditions such as chemotherapy and radiotherapy can compromise the immunity and self-renewal of epithelial cells leading to disruptions in the barriers that normally defend the host against microbial invasion, thus predisposing a patient to fungal infections.[3],[4] The prevalence of clinical fungal infection increased by 24% among head-and-neck cancer patients pre- and postradiotherapy/chemotherapy.[5]

Existing evidence on characterizing the oral microbiology of healthy individuals[6],[7] shows that 40% of the palliative patients lose their ability to communicate their oral health needs; therefore, they may suffer with treatable oral infections for a prolonged period of time.[8] This may contribute to the underreporting of oral infections among palliative patients, which may result in failure among health professionals to fully appreciate the problem. On the other hand, limited knowledge about oral conditions and related pathologies among palliative patients may continue to remain as a barrier for health-care practitioners to devise oral care interventions for this population.

Therefore, this systematic review aimed to synthesize the published evidence on the oral microbiology of palliative patients, with the following objectives:

  1. To identify the types of microflora in the oral cavity of palliative patients
  2. To identify the techniques used to investigate the microbiological presence in the oral cavity of palliative patients.



 » Methods Top


Data sources

Search strategy was devised by the research team comprising of a dentist (JSD), a palliative nurse (MRV), a medical doctor (DR), and a health-care researcher (ZR). Five electronic databases were used: ScienceDirect, PubMed, Google Scholar, Ovid, and EBSCOhost. Manual search was also conducted through key journals and reference list. We limited our search to articles published from January 2000 to December 2017. The search terms were “oral condition” OR “oral disease” OR “dental disease” OR “mouth disease” OR “mouth condition” OR mucositis OR stomatitis OR candidiasis OR cheilitis OR xerostomia OR “periodontal disease” OR halitosis OR thrush OR “angular cheilitis” OR “denture stomatitis” OR gingivitis OR periodontitis OR “mouth ulcer” OR “aphthous ulcer” AND palliative OR terminally-ill OR “terminally ill” OR “advanced disease” OR “advanced illness” OR dying OR end-of-life OR hospice OR cancer AND treatment OR intervention OR therapy OR management OR “oral care” OR “mouth care” OR “dental management” AND “end-of-life care.”

Study selection

Inclusion criteria specified that studies must be: (1) in full text, (2) in English language – to ensure no bias in translation, (3) research articles only – to ensure the articles retrieved had gone through peer-reviewed process, (4) published between year 2000 and 2017 – to ensure up-to-date research studies of the topic, (5) focused on palliative patients, and (6) analysis on microbiological evidence of oral conditions.

[Figure 1] illustrates the PRISMA flow chart of study selection process. The initial combined search identified 25,311 articles from 5 databases and 19 articles from other sources (manual searching and through references). The titles of the articles were reviewed, and duplicates were removed which resulted in 25,263 being excluded as they did not focus on oral conditions among palliative patients. The abstracts of the remaining 67 articles were read to ensure the relevance of the articles to our study. This resulted in 28 articles being excluded. Two reviewers (ZR and DR) then independently read the remaining 39 articles and coded them for inclusion or exclusion. Following the independent review, the two reviewers met to discuss preliminary findings and to reach a consensus on the studies to be included, and thirty studies were excluded. Thus, for the purpose of analysis, there were a total of nine articles.
Figure 1: Process of study selection

Click here to view


Data extraction

In the data extraction process, the study details are extracted in [Table 1]. This was done by two reviewers (ZR and DR). All reviewers discussed each article to reach consensus regarding the study details. The following information was extracted from each included study: author (s), year published, title, purpose, setting, origin of specimens, techniques, and microflora.
Table 1: Summary of studies included

Click here to view


Assessment of study quality

The quality of the identified studies was assessed using Joanna Briggs Institute critical appraisal tool (a checklist for analytical cross-sectional studies) which consisted of eight questions focusing on the clarity of inclusion criteria, study subjects, setting, validity and reliability of the exposure and outcome measures, issues on confounding factors, and appropriateness of statistical analysis used.[9] Each question has a choice of “yes,” “no,” “unclear,” or “not applicable” as an answer. Then, an overall appraisal was made whether to include or exclude each study, or to seek further information, with comments. Only the articles that were agreed by all involved researchers were included in this systematic review to inform the findings.

Data analysis

Extracted data from all included studies were analyzed using the Whittemore and Knafl principles of integrative review with four stages: data reduction, data display, data comparison, and conclusion drawing and verification.[10] At data reduction stage, all nine primary sources included in the integrative review were divided into a predetermined conceptual classification aligned with the aim of this review which is microbiological presence in the oral cavity of palliative patients and its identification techniques. Each primary source was reduced to a single page (available on request from authors). This helped us to systematically compare primary sources on specific issues, variables, and sample characteristics. It also allowed us to organize data into a manageable framework.

At Stage 2 – data display, the single-page data from the nine included studies are then extracted and displayed in [Table 1]. This helped us to visualize the patterns and relationships between and within primary data sources.

At Stage 3 – data comparison, we used constant comparison as a method of an iterative process of examining data to identify themes that had similar patterns and relations.

Finally, at Stage 4 – conclusion and verification, we verified patterns using primary data and identified any similarities, differences, and any spurious findings. These were dealt with in order to ensure that valuable information was not lost. Five meetings were held in order to identify and reach a consensus on the final themes.


 » Results Top


Characteristics of study

Overall, nine articles were found eligible and included in this review. The included study settings involved patients of advanced cancer conditions or palliative patients from five European, three Asian, and one American country. The total number of each study participants ranged from 54 to 390. The microbiological evidence of oral conditions among palliative patients of the nine eligible studies is summarized in [Table 1].

Common oral microorganisms present in palliative patients

Of nine studies, seven specifically reported Candida presence in the oral cavity of palliative patients.[3],[11],[12],[13],[14],[15],[16] Two studies reported the presence of yeast carriage.[17],[18] C. albicans was the predominant species with at least 50% of the total mycological infection reported in seven of nine studies [Table 1]. Other species of Candida reported were Candida glabrata, Candida dubliniensis, Candida tropicalis, Candida parapsilosis, and Candida krusei.

Predisposing factors for oral microbial pathology among palliative patient

Two studies reported dentures, xerostomia, and oral hygiene as predisposing factors for oral microbial pathology among palliative patients.[11],[17] Another study reported antibiotic and corticosteroid usage as predisposing factors for Candida species infections.[15] Another prospective study considered clinical findings and laboratory findings to develop appropriate treatment strategies.[18]

Association between oral symptoms and oral microbial flora

Only three studies reported a significant association between the presence of oral symptoms and the oral microbial flora, Jayachandran et al. found a significant association between dry mouth symptom and presence of Candida species.[3] Davies reported that oral yeast carriage and denture wearing were significantly associated (P< 0.006). Similarly, there was an association between oral yeast carriage and low salivary flow rate (P< 0.009).[11] Finally, a significant association was reported between prior treatment with triazole and isolation of fluconazole-resistant C. albicans (P < 0.005), but this relationship was not observed in C. glabrata isolates (P = 0.4).[13] The other six studies reported only the mean and percentage of various Candida species.

Techniques used for identification of microbiological presence

Of the nine studies, eight studies used oral swabs to identify the microbiological presence except one,[13] where a germ tube test was used for presumptive identification of C. albicans. In five studies, Sabouraud dextrose agar and/or CHROMagar were used for isolation of microbes,[3],[11],[12],[15],[17] one study used Trypticase agar slants,[13] another study used HiCrome Candida differential agar,[14] and two studies did not specify the type of agar used.[16],[18]

Two studies adapted antifungal susceptibility test that used minimum inhibition concentration of various antifungal agents such as azoles, nystatin, and amphotericin against different isolates of Candida species.[12],[16]

Another two studies performed Clinical and Laboratory Standards Institute-guided microbroth dilution method to detect antifungal susceptibility.[3],[14] Another study used the National Committee for Clinical Laboratory Standards guidelines to identify antifungal susceptibility.[13]


 » Discussion Top


Our systematic review found Candida as the most common microflora in the oral cavity of palliative patients, with C. albicans being the predominant species. This finding is worrying because although C. albicans is often present as commensal in the oral cavity, their transition as an opportunistic pathogen is made possible when the host defense is compromised,[19] for example, patients undergoing chemotherapy and/or radiotherapy targeting carcinomas and sarcomas.[19] This is evident as oral candidiasis is common in head-and-neck cancer patients,[19] with 70%–75% Candida carriage in patients taking chemotherapy and/or radiotherapy.[20] A study reported that chemotherapy and/or radiotherapy causes mucositis and changes in saliva consistency. Xerostomia or thick saliva makes the oral environment conducive for fungal colonization.[21]

Oral candidiasis is also a common side effect of cancer treatments which harm the body's mucous membranes and further weaken the immune system, making it more difficult for the body to fight off the Candida infection.[16],[22] Studies have suggested the use of antifungal medications during cancer treatment to prevent an infection.[16],[22] In palliative conditions, diverse form of antifungal medications, such as mouthwashes, gels, ointments, capsules, or given as an infusion, and can help to have an effect on a limited local region (topical), on the entire body (systemic) or with a combined effect. However, no evidence is available whether these antifungal medications can help reduce other oral candidiasis symptoms such as pain or difficulty swallowing.

There are various techniques available for the isolation of Candida within the oral cavity such as the use of smear, an imprint culture, collection of whole saliva, concentrated oral rinse, and mucosal biopsy,[23] and the majority of our included studies only used oral swabs for isolation. It is a relatively simple method of detecting growth of microflora, site specific, and can obtain semi-quantitative estimation of Candida, and this technique is difficult to standardize.[23] Since Candida is the resident microflora within the oral cavity, a more reliable and appropriate isolation methods are required to ascertain its presence along with their quantity.


 » Conclusion Top


To our knowledge, this study is the first systematic review taking into account the techniques to identify the oral microflora among palliative patients. It is hoped that the information generated from this review will lead to a better understanding of oral conditions among palliative patients in order to direct the treatment options and enhance the quality of care for these terminally ill patients. Future studies with multicenter approach may help to develop standardized clinical guidelines for oral care of palliative patients.

Acknowledgement

We would like to thank Universiti Brunei Darussalam for the award of a grant that makes this project possible.

makes this project possible.

Financial support and sponsorship

This study was financially supported by Universiti Brunei Darussalam, Grant information: UBD/OAVCRI/CRGWG (014)/171001.

Conflicts of interest

There are no conflicts of interest.



 
 » References Top

1.
Aas JA, Paster BJ, Stokes LN, Olsen I, Dewhirst FE. Defining the normal bacterial flora of the oral cavity. J Clin Microbiol 2005;43:5721-32.  Back to cited text no. 1
    
2.
Singh A, Verma R, Murari A, Agrawal A. Oral candidiasis: An overview. J Oral Maxillofac Pathol 2014;18:S81-5.  Back to cited text no. 2
    
3.
Jayachandran AL, Katragadda R, Thyagarajan R, Vajravelu L, Manikesi S, Kaliappan S, et al. Oral candidiasis among cancer patients attending a tertiary care hospital in chennai, South India: An evaluation of clinicomycological association and antifungal susceptibility pattern. Can J Infect Dis Med Microbiol 2016;2016:8758461.  Back to cited text no. 3
    
4.
Teoh F, Pavelka N. How chemotherapy increases the risk of systemic candidiasis in cancer patients: Current paradigm and future directions. Pathogens 2016;5. pii: E6.  Back to cited text no. 4
    
5.
Lalla RV, Latortue MC, Hong CH, Ariyawardana A, D'Amato-Palumbo S, Fischer DJ, et al. Asystematic review of oral fungal infections in patients receiving cancer therapy. Support Care Cancer 2010;18:985-92.  Back to cited text no. 5
    
6.
Ohazama J, Motegi E, Nomura M, Miyazaki H, Takane Y, Harazaki M, et al. Oral flora in independent over 80-year-olds with more than 20 teeth. Bull Tokyo Dent Coll 2006;47:1-4.  Back to cited text no. 6
    
7.
Paster BJ, Boches SK, Galvin JL, Ericson RE, Lau CN, Levanos VA, et al. Bacterial diversity in human subgingival plaque. J Bacteriol 2001;183:3770-83.  Back to cited text no. 7
    
8.
Chen X, Chen H, Douglas C, Preisser JS, Shuman SK. Dental treatment intensity in frail older adults in the last year of life. J Am Dent Assoc 2013;144:1234-42.  Back to cited text no. 8
    
9.
Joanna Briggs Institute. Checklist for Analytical Cross Sectional Studies Critical Appraisal Checklist for Analytical Cross Sectional Studies. Ch. 2. Joanna Briggs Institute; 2017. Available from: http://joannabriggs.org/research/critical-appraisal-tools.htmlwww.joannabriggs.org. [Last accessed on 2018 Aug 13].  Back to cited text no. 9
    
10.
Whittemore R, Knafl K. The integrative review: Updated methodology. J Adv Nurs 2005;52:546-53.  Back to cited text no. 10
    
11.
Davies AN, Brailsford S, Broadley K, Beighton D. Oral yeast carriage in patients with advanced cancer. Oral Microbiol Immunol 2002;17:79-84.  Back to cited text no. 11
    
12.
Sh A. Oral candidiasis amongst cancer patients at Qods hospitals in Sanandaj. Afr J Cln Exper Microbiol 2011;12:129-32. Available from: https://www.ajol.info/index.php/ajcem/article/viewFile/66913/54910. [Last accessed on 2018 Oct 10].  Back to cited text no. 12
    
13.
Safdar A, Chaturvedi V, Cross EW, Park S, Bernard EM, Armstrong D, et al. Prospective study of Candida species in patients at a comprehensive cancer center. Antimicrob Agents Chemother 2001;45:2129-33.  Back to cited text no. 13
    
14.
Suhail Lone D, Bashir D, Bali D, Sajad S, Bashir H, Ahmad D, et al. Oral Candida colonization and infection in cancer patients and their antifungal susceptibility in a tertiary care hospital. Int J Adv Res 2014;2:541-50. Available from: http://www.journalijar.com. [Last accessed on 2018 Oct 10].  Back to cited text no. 14
    
15.
Davies AN, Brailsford SR, Beighton D. Oral candidosis in patients with advanced cancer. Oral Oncol 2006;42:698-702.  Back to cited text no. 15
    
16.
Astvad K, Johansen HK, Høiby N, Steptoe P, Ishøy T. Oropharyngeal candidiasis in palliative care patients in Denmark. J Palliat Med 2015;18:940-4.  Back to cited text no. 16
    
17.
Davies AN, Brailsford SR, Beighton D, Shorthose K, Stevens VC. Oral candidosis in community-based patients with advanced cancer. J Pain Symptom Manage 2008;35:508-14.  Back to cited text no. 17
    
18.
Alt-Epping B, Nejad RK, Jung K, Gross U, Nauck F. Symptoms of the oral cavity and their association with local microbiological and clinical findings – A prospective survey in palliative care. Support Care Cancer 2012;20:531-7.  Back to cited text no. 18
    
19.
Jain M, Shah R, Chandolia B, Mathur A, Chauhan Y, Chawda J, et al. The oral carriage of Candida in oral cancer patients of indian origin undergoing radiotherapy and/or chemotherapy. J Clin Diagn Res 2016;10:ZC17-20.  Back to cited text no. 19
    
20.
Samaranayake LP, Calman KC, Ferguson MM, Kaye SB, MacFarlane TW, Main B, et al. The oral carriage of yeasts and coliforms in patients on cytotoxic therapy. J Oral Pathol 1984;13:390-3.  Back to cited text no. 20
    
21.
Silverman S Jr. Luangjarmekorn L, Greenspan D. Occurrence of oral Candida in irradiated head and neck cancer patients. J Oral Med 1984;39:194-6.  Back to cited text no. 21
    
22.
Institute for Quality and Efficiency in Health Care. Oral Thrush: Prevention During Cancer Treatment. Institute for Quality and Efficiency in Health Care; 2016. https://www.ncbi.nlm.nih.gov/books/NBK367590/. [Last accessed on 2018 Oct 11].  Back to cited text no. 22
    
23.
Byadarahally Raju S, Rajappa S. Isolation and identification of Candida from the oral cavity. ISRN Dent 2011;2011:487921.  Back to cited text no. 23
    


    Figures

  [Figure 1]
 
 
    Tables

  [Table 1]



 

Top
Print this article  Email this article
Online since 1st October '05
Published by Wolters Kluwer - Medknow